CABERGLOW 0.50 Mg Tablet : Uses, Interactions, Mechanism of Action - DrugBank

May 13, 2024

CABERGLOW 0.50 

Cabergoline IP(0.5mg)

CABERGLOW 0.50, containing Cabergoline IP 0.5mg, is a medication known for its multifaceted applications in treating various medical conditions. From its therapeutic uses to dosage guidelines, potential side effects, composition, and pricing considerations, this comprehensive guide aims to provide you with all the necessary information you need to understand this medication better.

Uses:

CABERGLOW 0.50 finds its utility across several medical domains:

  1. Hyperprolactinemia: One of the primary indications for Cabergoline is the treatment of hyperprolactinemia, a condition characterized by elevated levels of prolactin hormone in the blood. It helps in reducing prolactin secretion from the pituitary gland, thereby alleviating associated symptoms such as irregular menstruation, infertility, and galactorrhea.

  2. Parkinson's Disease: Cabergoline is also prescribed in the management of Parkinson's disease, a progressive neurodegenerative disorder. It acts as a dopamine agonist, stimulating dopamine receptors in the brain and thereby improving motor function and reducing symptoms like tremors, rigidity, and bradykinesia.

  3. Acromegaly: In cases of acromegaly, a hormonal disorder characterized by excessive growth hormone production, Cabergoline may be used as an adjunctive therapy to reduce growth hormone levels and manage symptoms like enlarged hands and feet, facial changes, and organ enlargement.

Dosage:

The dosage of CABERGLOW 0.50 may vary depending on the medical condition being treated and individual patient factors. It is crucial to follow the prescribed dosage regimen provided by your healthcare provider. Typically, for hyperprolactinemia, the initial recommended dose ranges from 0.25 to 1 mg per week, divided into two or more doses. For Parkinson's disease, the initial dose may be lower, starting at 0.5 mg per week, and gradually titrated based on response and tolerability.

Price:

The price of CABERGLOW 0.50 can vary based on factors such as the manufacturer, dosage strength, and location. It is available in both generic and brand formulations, with generic versions often being more affordable. Patients are advised to check with local pharmacies or online platforms to compare prices and avail any discounts or insurance coverage that may be applicable.

Side Effects:

While CABERGLOW 0.50 is generally well-tolerated, like any medication, it may cause certain side effects in some individuals. Common side effects may include:

  1. Nausea and vomiting
  2. Headache
  3. Dizziness
  4. Fatigue
  5. Constipation
  6. Orthostatic hypotension (low blood pressure when standing up)

In some cases, more severe side effects such as hallucinations, psychosis, and cardiac valve disorders have been reported, particularly with long-term use and higher doses. It is essential to promptly report any unusual symptoms or adverse reactions to your healthcare provider for proper evaluation and management.

Composition:

CABERGLOW 0.50 contains Cabergoline IP 0.5mg as its active ingredient. Inactive ingredients may vary depending on the formulation and manufacturer and may include fillers, binders, and coloring agents. Patients with known allergies or sensitivities to any components of the medication should exercise caution and consult their healthcare provider before initiating treatment.

Precautions and Warnings:

Before taking CABERGLOW 0.50, it is important to inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking, including over-the-counter drugs and herbal supplements. Certain medications may interact with Cabergoline, potentially affecting its efficacy or increasing the risk of adverse effects.

Pregnant women, breastfeeding mothers, and individuals with a history of certain medical conditions such as liver disease, cardiovascular disorders, or psychiatric disorders should use CABERGLOW 0.50 with caution and under the supervision of a healthcare professional.

Conclusion:

In conclusion, CABERGLOW 0.50, with its active ingredient Cabergoline IP 0.5mg, offers a versatile therapeutic option for various medical conditions, including hyperprolactinemia, Parkinson's disease, restless legs syndrome, and acromegaly. By understanding its uses, dosage, potential side effects, composition, and pricing considerations, patients can make informed decisions in consultation with their healthcare providers to optimize treatment outcomes while minimizing risks. Always follow your healthcare provider's guidance regarding the appropriate use of CABERGLOW 0.50 for your specific condition. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

SHARE WITH